Pages that link to "Q83554362"
Jump to navigation
Jump to search
The following pages link to Gene table of monogenic neuromuscular disorders (nuclear genome only) Vol 19. No 1 January 2009 (Q83554362):
Displaying 13 items.
- Mutation in Exon 1f of PLEC, Leading to Disruption of Plectin Isoform 1f, Causes Autosomal-Recessive Limb-Girdle Muscular Dystrophy (Q24309219) (← links)
- Prevalence of genetic muscle disease in Northern England: in-depth analysis of a muscle clinic population (Q33685609) (← links)
- Enhanced Ca²⁺ influx from STIM1-Orai1 induces muscle pathology in mouse models of muscular dystrophy. (Q33784460) (← links)
- Molecular diagnosis of hereditary inclusion body myopathy by linkage analysis and identification of a novel splice site mutation in GNE. (Q33943919) (← links)
- Heterozygous deletion of a 2-Mb region including the dystroglycan gene in a patient with mild myopathy, facial hypotonia, oral-motor dyspraxia and white matter abnormalities (Q34329257) (← links)
- Mitigation of muscular dystrophy in mice by SERCA overexpression in skeletal muscle (Q34627089) (← links)
- Interventions for muscular dystrophy: molecular medicines entering the clinic (Q35014916) (← links)
- Preclinical studies with umbilical cord mesenchymal stromal cells in different animal models for muscular dystrophy (Q35113901) (← links)
- Therapy development for spinal muscular atrophy in SMN independent targets. (Q36014761) (← links)
- Deletion of periostin reduces muscular dystrophy and fibrosis in mice by modulating the transforming growth factor-β pathway (Q36079434) (← links)
- The role of the neuromuscular medicine and physiatry specialists in the multidisciplinary management of neuromuscular disease (Q36351131) (← links)
- Perceptions of equine-assisted activities and therapies by parents and children with spinal muscular atrophy (Q37673224) (← links)
- Spinal muscular atrophy disease: a literature review for therapeutic strategies (Q37714861) (← links)